Catriona Yale

Insider Reports History

Entity
Individual
Location
C/O Akero Therapeutics Inc., 170 Harbor Way 3 Rd Floor, South San Francisco, CA
Signature
/s/ Jonathan Young, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Catriona Yale:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Akero Therapeutics, Inc. Chief Development Officer Common Stock 74.2K $2.14M $28.82 Nov 15, 2024 Direct
Akero Therapeutics, Inc. Chief Development Officer Stock Option (Right to Buy) 53.4K Nov 15, 2024 Direct

Insider Reports Filed by Catriona Yale

Symbol Company Period Transactions Value $ Form Type Date Filed Role
AKRO Akero Therapeutics, Inc. Nov 15, 2024 4 -$60.1K 4 Nov 19, 2024 Chief Development Officer
AKRO Akero Therapeutics, Inc. Nov 6, 2024 4 -$346K 4 Nov 8, 2024 Chief Development Officer
AKRO Akero Therapeutics, Inc. Oct 30, 2024 6 -$230K 4 Nov 1, 2024 Chief Development Officer
AKRO Akero Therapeutics, Inc. Oct 14, 2024 8 -$624K 4 Oct 16, 2024 Chief Development Officer
AKRO Akero Therapeutics, Inc. Sep 19, 2024 3 -$149K 4 Sep 23, 2024 Chief Development Officer
AKRO Akero Therapeutics, Inc. Sep 16, 2024 9 -$226K 4 Sep 18, 2024 Chief Development Officer
AKRO Akero Therapeutics, Inc. Sep 10, 2024 1 -$16.7K 4 Sep 13, 2024 Chief Development Officer
AKRO Akero Therapeutics, Inc. Sep 3, 2024 3 -$25.6K 4 Sep 5, 2024 Chief Development Officer
AKRO Akero Therapeutics, Inc. Aug 23, 2024 6 -$378K 4 Aug 28, 2024 Chief Development Officer
AKRO Akero Therapeutics, Inc. Jun 28, 2024 1 $21.2K 4 Jul 2, 2024 Chief Development Officer
AKRO Akero Therapeutics, Inc. Jun 11, 2024 1 -$64K 4 Jun 13, 2024 Chief Development Officer
AKRO Akero Therapeutics, Inc. Mar 13, 2024 1 -$20.5K 4 Mar 15, 2024 Chief Development Officer
AKRO Akero Therapeutics, Inc. Mar 4, 2024 5 -$445K 4 Mar 6, 2024 Chief Development Officer
AKRO Akero Therapeutics, Inc. Dec 14, 2023 1 -$12.4K 4 Dec 18, 2023 Chief Development Officer
AKRO Akero Therapeutics, Inc. Dec 8, 2023 2 $0 4 Dec 12, 2023 Chief Development Officer
AKRO Akero Therapeutics, Inc. Sep 13, 2023 5 -$240K 4 Sep 25, 2023 Chief Development Officer
AKRO Akero Therapeutics, Inc. Aug 28, 2023 4 -$251K 4 Aug 30, 2023 Chief Development Officer
AKRO Akero Therapeutics, Inc. Jun 21, 2023 4 -$1.73M 4 Jun 23, 2023 Chief Development Officer
AKRO Akero Therapeutics, Inc. Jun 13, 2023 1 -$32.6K 4 Jun 15, 2023 Chief Development Officer
AKRO Akero Therapeutics, Inc. Mar 10, 2023 1 -$30.5K 4 Mar 14, 2023 Chief Development Officer
AKRO Akero Therapeutics, Inc. Jan 13, 2023 4 -$253K 4 Jan 18, 2023 Chief Development Officer
AKRO Akero Therapeutics, Inc. Dec 16, 2022 1 $0 4 Dec 20, 2022 Chief Development Officer
AKRO Akero Therapeutics, Inc. Dec 9, 2022 4 -$216K 4 Dec 13, 2022 Chief Development Officer
AKRO Akero Therapeutics, Inc. Nov 10, 2022 2 -$197K 4 Nov 14, 2022 Chief Development Officer
AKRO Akero Therapeutics, Inc. Oct 10, 2022 1 -$190K 4 Oct 12, 2022 Chief Development Officer
AKRO Akero Therapeutics, Inc. Sep 13, 2022 2 -$1.1M 4 Sep 15, 2022 Chief Development Officer
AKRO Akero Therapeutics, Inc. Sep 9, 2022 3 $9.25K 4 Sep 13, 2022 Chief Development Officer
AKRO Akero Therapeutics, Inc. Dec 8, 2021 1 $0 4 Dec 10, 2021 Chief Development Officer
AKRO Akero Therapeutics, Inc. Oct 15, 2021 2 -$270K 4 Oct 18, 2021 Chief Development Officer
AKRO Akero Therapeutics, Inc. Sep 15, 2021 2 -$309K 4 Sep 17, 2021 Chief Development Officer
AKRO Akero Therapeutics, Inc. Aug 16, 2021 1 -$188K 4 Aug 17, 2021 Chief Development Officer
AKRO Akero Therapeutics, Inc. Jul 15, 2021 1 -$209K 4 Jul 19, 2021 Chief Development Officer